EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›OMQS

OMQS

OMNIQ Corp.

Next earnings Aug 17, 2026

Last earnings +0.0% on 2026-05-20

Avoid
$0.13
▲ +33.92%
$0.13▲ +95.30%
over 1Y
L $0.05EODHDH $0.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+33.9%
1W+0.0%
1M-0.2%
3M+27.3%
YTD-1.0%
1Y+95.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Conservative balance sheet (liabilities/equity -3.06x); but revenue declined -5.5% YoY.

Revenue (FY2025) $33.0M · FY2025

OMNIQ Corp. shows $33.0M in FY2025 revenue (-5.5% YoY), a -0.4% net margin, and 1.1% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$78.3M$101M$81.2M$34.9M$33.0M
Gross profit$16.7M$22.1M$15.7M$5.63M$9.04M
Operating income-$10.5M-$9.55M-$26.2M-$6.62M-$3.85M
Net income-$13.4M-$13.7M-$29.4M-$10.0M-$137K
Diluted EPS——-$3.50-$0.94-$0.01
Net margin-17.1%-13.6%-36.2%-28.7%-0.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.82M
EV / EBITDA—
EV / Sales0.1
EV / FCF0.6
P / FCF0.3
PEG (trailing)—
Earnings yield-7.0%
FCF yield349.2%

Quality & risk

ROIC (est.)—
Free cash flow$6.81M
Total debt$4.25M
Net cash-$1.87M
Altman Z-Score-6.44 distress
Piotroski F-Score6/9

Capital returns

Buyback yield0.1%
Dividend yield (est.)74.2%
Shareholder yield74.3%
Shares Δ YoY+41.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-05-15). Worth a closer look.
  1. 8-K Reg FD disclosure2026-06-02
  2. 8-K Earnings results2026-05-20
  3. 10-Q Quarterly report2026-05-20
  4. NT 10-Q Late filing notice2026-05-15
  5. 8-K Earnings results2026-04-16
  6. 10-K Annual report2026-04-15
  7. NT 10-K Late filing notice2026-04-01
  8. 8-K Reg FD disclosure2026-03-02
  9. 8-K Reg FD disclosure2026-02-17

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-022026-06-02open ↗8-KPeriod ending 2026-05-202026-05-20open ↗10-QPeriod ending 2026-03-312026-05-20open ↗NT 10-QPeriod ending 2026-03-312026-05-15open ↗4Period ending 2025-12-082026-04-16open ↗8-KPeriod ending 2026-04-152026-04-16open ↗10-KPeriod ending 2025-12-312026-04-15open ↗NT 10-KPeriod ending 2025-12-312026-04-01open ↗8-KPeriod ending 2026-03-022026-03-02open ↗8-KPeriod ending 2026-02-172026-02-17open ↗8-KPeriod ending 2026-01-272026-01-27open ↗8-KPeriod ending 2025-12-082025-12-08open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueA+
GrowthB-
ProfitabilityF
Financial healthF
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$33.0M
-5.5% YoY
Net margin
-0.4%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$33.0M-5.5%
Net income-$137K+98.6%
Gross profit$9.04M+60.5%
Operating income-$3.85M+41.9%
Diluted EPS-$0.01+98.9%
Cash & equivalents$2.39M+1.7%
Total assets$26.2M-39.9%
Total liabilities$38.9M-55.6%
Stockholders' equity-$12.7M+71.1%
Gross: 27.4%Op.: -11.7%L/E: -3.06x

Frequently asked

Is OMNIQ Corp. (OMQS) a buy?
OMQS currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -3.06x); but revenue declined -5.5% YoY.
What is OMNIQ Corp.'s quality score?
OMQS scores 46.94117647058824/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000278165, latest 10-Q filed 2026-05-20) · EODHD · as of 6/23/2026, 1:57:34 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-12-08
Lustgarten Shai Shalom
Chief Executive Officer
Award1.50M @ $0.10$150K
2025-07-11
Lustgarten Shai Shalom
Chief Executive Officer
Award450K @ $0.07$31.5K
2023-05-22
Nissenson Neev
Chief Financial Officer
Sell1.00K @ $5.99$5.99K
2023-05-22
Nissenson Neev
Chief Financial Officer
Sell2.29K @ $5.90$13.5K
2023-05-18
Nissenson Neev
Chief Financial Officer
Sell5.00K @ $5.77$28.8K
2023-05-18
Nissenson Neev
Chief Financial Officer
Sell1.00K @ $5.85$5.85K
2023-03-06
Nissenson Neev
Chief Financial Officer
Exercise10.4K @ $2.40$25.1K
2023-03-06
Shalem Yaron
Director
Exercise10.4K @ $2.40$25.1K
2023-03-06
Lustgarten Shai Shalom
Chief Executive Officer
Exercise52.2K @ $2.40$125K
2023-03-06
MacMillan Andrew J
Director
Exercise10.4K @ $2.40$25.1K

Earnings history

beat/miss · move
2026-05-20—▲ 0.00%8-K ↗
2026-04-16—▲ 0.00%8-K ↗
2025-11-14—▼ -10.84%8-K ↗
2016-11-22—▲ 0.00%8-K ↗
2016-08-23—▲ +0.91%8-K ↗
2016-05-26—▲ +1.94%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
$170 Billion in Border and Security Funding Highlights Growing Demand for AI-Powered Surveillance and Machine Vision TechnologiesBullish
globenewswire.com· 2026-06-02
OMNIQ Reports First Quarter 2026 Financial ResultsBullish
globenewswire.com· 2026-05-20
OMNIQ Reports 60% Increase in Gross Profit for 2025Bullish
globenewswire.com· 2026-04-15
Fortune 100 Tech Leader Deploys OMNIQ AI-based LPR Across Key Silicon Valley LocationsBullish
globenewswire.com· 2026-01-27
OMNIQ reports Q3 resultsBullish
seekingalpha.com· 2025-11-14
OMNIQ Reports Third Quarter Financial ResultsBullish
globenewswire.com· 2025-11-14

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score47 vs 67
Revenue growth-5.5% vs 7.1%
Net margin-0.4% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 2d
Bullish
+0.18
vs typical · 2 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.